Quantcast

Latest Amides Stories

2014-02-04 08:34:36

Robust Clinical Data on Filanesib Presented at ASH Supporting Announced Registration Program BOULDER, Colo., Feb. 4, 2014 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY) today reported results for the second quarter of its fiscal year ending June 30, 2014. (Logo: http://photos.prnewswire.com/prnh/20121029/LA02195LOGO) Revenue for the second quarter of fiscal 2014 was $14.1 million, compared to $18.4 million for the same period last year. The decrease was due to license...

2014-01-31 23:33:15

The DrugRisk Center is the largest source on the Web for information on prescription drug research, side effects and legal news. Visit http://www.DrugRisk.com Chicago, IL (PRWEB) January 31, 2014 The prescription drug safety advocates at DrugRisk.com have added new information for patients taking the blood thinner Pradaxa. A federal judge overseeing lawsuits alleging the drug caused internal bleeding injury or death recently scheduled the first cases for trial*. DrugRisk is a free...

2014-01-29 23:28:36

As Pradaxa Bleeding Lawsuits Mount, FDA Announces Plan for Large Scale Assessment Comparing Pradaxa Bleeding Rates to Warfarin. Columbus, OH (PRWEB) January 29, 2014 The Pradaxa lawyers at Wright & Schulte LLC were pleased with news that the U.S. Food & Drug Administration (FDA) has planned a large scale-assessment comparing Pradaxa bleeding rates to those associated with warfarin. The announcement of the study comes as thousands of Pradaxa lawsuits that allege use of the drug...

2014-01-29 16:28:52

MALVERN, Pa., Jan. 29, 2014 /PRNewswire/ -- Endo Health Solutions (Nasdaq: ENDP) today confirmed that the United States District Court for the District of Delaware ruled that United States Patent No. 5,464,864, Endo's patent covering frovatriptan, the active ingredient in FROVA(® )(frovatriptan succinate) tablets, is valid and infringed. The Court's decision prevents Mylan from marketing its generic version of FROVA(®) in the U.S. before Endo's patent expires November 8, 2015,...

2014-01-28 23:32:17

http://www.DrugNews.net is the web’s premier source for prescription device warnings, research, side effects and legal news. Visit the DrugNews Center today. New York, NY (PRWEB) January 28, 2014 The prescription drug safety advocates at DrugNews.net have added new information to the site for patients taking the blood thinner Pradaxa. The resource center learned the FDA is planning a new study of the drug’s safety* and court records show the number of lawsuits alleging internal...

2014-01-27 23:01:00

The Firm is investigating Pradaxa lawsuits on behalf of individuals who suffered internal bleeding, including cerebral and gastrointestinal hemorrhage, allegedly due to Pradaxa. New York, NY (PRWEB) January 27, 2014 Thousands of Pradaxa lawsuits (http://www.pradaxalawsuithelp.com/) that allege the blood thinners caused patients to suffer serious, and even deadly, episodes of internal bleeding, are moving forward in U.S. District Court, Southern District of Illinois, Bernstein Liebhard...

2014-01-24 23:23:38

National network of attorneys will resume availability to consumers inquiring about legal options to seek compensation over allegations that Pradaxa may cause bleeding problems. San Diego, CA (PRWEB) January 24, 2014 http://www.resource4thepeople.com/defectivedrugs/pradaxa-lawsuits.html Resource4thePeople announced today that its national network of attorneys will continue to offer free consultations in 2014 to consumers who are seeking compensation in connection with allegations that the...

2014-01-23 23:29:58

National network of lawyers will resume availability for inquiries from consumers seeking compensation in lawsuits alleging links between diabetes medications Victoza, Janumet, Januvia and Byetta and pancreatic cancer. San Diego, CA (PRWEB) January 23, 2014 http://www.resource4thepeople.com/defectivedrugs/victoza-lawsuit.html Resource4thePeople announced today that its national network of attorneys will continue to offer free consultations in 2014 to consumers inquiring about allegations...

2014-01-22 23:30:56

National network of lawyers will resume availability for inquiries from consumers seeking compensation in lawsuits alleging links between diabetes medications Janumet, Januvia, Byetta and Victoza and pancreatic cancer. San Diego, CA (PRWEB) January 22, 2014 http://www.resource4thepeople.com/defectivedrugs/januvia.html Resource4thePeople announced today that its national network of attorneys will continue to offer free consultations in 2014 to consumers inquiring about allegations in...

2014-01-21 23:28:42

National network of lawyers will resume availability for inquiries from consumers seeking compensation in lawsuits alleging links between diabetes medications Byetta, Januvia, Janumet and Victoza and pancreatic cancer. San Diego, CA (PRWEB) January 21, 2014 http://www.resource4thepeople.com/defectivedrugs/byetta.html Resource4thePeople announced today that its national network of attorneys will continue to offer free consultations in 2014 to consumers inquiring about allegations in...


Word of the Day
virgule
  • A punctuation mark (/) used to separate related items of information.
  • A little rod; a twig.
This word comes from the Late Latin 'virgula,' accentual mark, a diminutive of 'virga,' rod.
Related